The clinical trials below are available in the specialty you selected. Choose a different specialty.
QGE 031 in the treatment of patients with bullous pemphigoid
Randomized, placebo-controlled study evaluating the efficacy, safety, PKs, and PDs of QGE031 in these patients who are refractory to oral steroid treatment. (REF# 00042456)
Phase 3 study to evaluate the efficacy and safety of Brodalumab compared with placebo and ustekinumab in subjects with moderate to severe plaque psoriasis
Adults 18-75 with moderate to severe plaque psoriasis. Injectable medications being compared (Stelara versus Ustekinumab). 1/6 chance of Placebo. (REF# 00038071)